Anthony Gibney's most recent trade in Aura Biosciences Inc was a trade of 250,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aura Biosciences Inc | Anthony S. Gibney | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Anthony S. Gibney | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 150,000 | 206,933 | - | 0 | Common Stock | |
| Aura Biosciences Inc | Anthony S. Gibney | See Remarks | Purchase of securities on an exchange or from another person at price $ 4.90 per share. | 16 May 2025 | 50,000 | 58,452 | - | 4.9 | 245,000 | Common Stock |
| Aura Biosciences Inc | Anthony S. Gibney | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 May 2025 | 12,500 | 12,500 | - | - | Common Stock Warrants (right to buy) | |
| Aura Biosciences Inc | Anthony S. Gibney | See Remarks | Sale of securities on an exchange or to another person at price $ 5.15 per share. | 16 May 2025 | 1,519 | 56,933 | - | 5.2 | 7,823 | Common Stock |
| Clearside Biomedical Inc | Anthony S. Gibney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Clearside Biomedical Inc | Anthony Gibney | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 17 Apr 2024 | 93,290 | 100,000 (0%) | 0% | 1.3 | 121,277 | Common Stock |
| Clearside Biomedical Inc | Anthony Gibney | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 17 Apr 2024 | 6,710 | 6,710 (0%) | 0% | 1.3 | 8,388 | Common Stock |
| Clearside Biomedical Inc | Anthony Gibney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) |